[HTML][HTML] Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus …

M Lanari, E Venturini, L Pierantoni, G Stera… - Italian Journal of …, 2022 - Springer
The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of
the therapeutic options. The Human recombinant monoclonal antibodies (mAbs) have …

[HTML][HTML] COVID-19 in children and adolescents: characteristics and specificities in immunocompetent and oncohematological patients

F Mercolini, S Cesaro - Mediterranean Journal of Hematology and …, 2022 - ncbi.nlm.nih.gov
SARS-CoV-2 pandemic affected fewer children and adolescents with lower morbidity and
mortality rates than those reported for adults. This review focused on the clinical course, risk …

COVID-19 in children: update on diagnosis and management

S Esposito, L Abate, SR Laudisio… - … in respiratory and …, 2021 - thieme-connect.com
In December 2019, a new infectious disease called coronavirus disease 2019 (COVID-19)
attributed to the new virus named severe scute respiratory syndrome coronavirus 2 (SARS …

A COVID-19 primer for primary care clinicians

MC Burkhardt, K Winter, SJ Alter, JM Klatte - Current Problems in Pediatric …, 2022 - Elsevier
COVID-19 has challenged primary care clinicians to rapidly learn new information and adapt
clinical practice in response to the continuous evolution of prevention, diagnosis, and …

[HTML][HTML] Use of Remdesivir in children with COVID-19: report of an Italian multicenter study

L Romani, M Roversi, S Bernardi, E Venturini… - Italian Journal of …, 2024 - Springer
Background COVID-19 is generally milder in children than in adults, however severe
infection has been described in some patients. Few data are available on use of Remdesivir …